Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.67
IVC's Cash-to-Debt is ranked lower than
74% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. IVC: 0.67 )
Ranked among companies with meaningful Cash-to-Debt only.
IVC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: 1.92
Current: 0.67
0
1.92
Equity-to-Asset 0.42
IVC's Equity-to-Asset is ranked lower than
71% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. IVC: 0.42 )
Ranked among companies with meaningful Equity-to-Asset only.
IVC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.47 Max: 0.61
Current: 0.42
0.26
0.61
Debt-to-Equity 0.56
IVC's Debt-to-Equity is ranked lower than
58% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 0.29 vs. IVC: 0.56 )
Ranked among companies with meaningful Debt-to-Equity only.
IVC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.67 Max: 1.95
Current: 0.56
0.04
1.95
Piotroski F-Score: 3
Altman Z-Score: 2.00
Beneish M-Score: -2.72
WACC vs ROIC
19.21%
-3.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating Margin % -3.13
IVC's Operating Margin % is ranked lower than
58% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.45 vs. IVC: -3.13 )
Ranked among companies with meaningful Operating Margin % only.
IVC' s Operating Margin % Range Over the Past 10 Years
Min: -4.63  Med: 0.17 Max: 4.99
Current: -3.13
-4.63
4.99
Net Margin % -6.42
IVC's Net Margin % is ranked lower than
59% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.77 vs. IVC: -6.42 )
Ranked among companies with meaningful Net Margin % only.
IVC' s Net Margin % Range Over the Past 10 Years
Min: -6.42  Med: 0.1 Max: 2.48
Current: -6.42
-6.42
2.48
ROE % -14.35
IVC's ROE % is ranked lower than
63% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. IVC: -14.35 )
Ranked among companies with meaningful ROE % only.
IVC' s ROE % Range Over the Past 10 Years
Min: -14.35  Med: 0.26 Max: 6.67
Current: -14.35
-14.35
6.67
ROA % -6.68
IVC's ROA % is ranked lower than
57% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.49 vs. IVC: -6.68 )
Ranked among companies with meaningful ROA % only.
IVC' s ROA % Range Over the Past 10 Years
Min: -6.68  Med: 0.11 Max: 3.08
Current: -6.68
-6.68
3.08
ROC (Joel Greenblatt) % -17.93
IVC's ROC (Joel Greenblatt) % is ranked lower than
58% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 6.15 vs. IVC: -17.93 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
IVC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -29.81  Med: 0.92 Max: 23.37
Current: -17.93
-29.81
23.37
3-Year Revenue Growth Rate -8.30
IVC's 3-Year Revenue Growth Rate is ranked lower than
79% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. IVC: -8.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
IVC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -8.3  Med: 7.5 Max: 18.5
Current: -8.3
-8.3
18.5
3-Year EPS without NRI Growth Rate -8.10
IVC's 3-Year EPS without NRI Growth Rate is ranked lower than
65% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. IVC: -8.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
IVC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -74.2  Med: 19.1 Max: 239.1
Current: -8.1
-74.2
239.1
GuruFocus has detected 7 Warning Signs with Invacare Corp $IVC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» IVC's 30-Y Financials

Financials (Next Earnings Date: 2017-10-31 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

IVC Guru Trades in Q3 2016

Mariko Gordon 2,983,947 sh (+131.94%)
Charles Brandes 1,436,472 sh (+51.04%)
Chuck Royce 925,850 sh (+6.07%)
Barrow, Hanley, Mewhinney & Strauss 269,082 sh (+5.88%)
HOTCHKIS & WILEY 1,391,665 sh (-0.39%)
Arnold Schneider 136,505 sh (-6.83%)
Jim Simons 25,200 sh (-92.18%)
» More
Q4 2016

IVC Guru Trades in Q4 2016

Charles Brandes 1,921,649 sh (+33.78%)
Chuck Royce 1,084,730 sh (+17.16%)
Barrow, Hanley, Mewhinney & Strauss 305,349 sh (+13.48%)
Jim Simons Sold Out
Mariko Gordon 2,972,948 sh (-0.37%)
HOTCHKIS & WILEY 1,385,495 sh (-0.44%)
Arnold Schneider 127,525 sh (-6.58%)
» More
Q1 2017

IVC Guru Trades in Q1 2017

Chuck Royce 1,211,712 sh (+11.71%)
Charles Brandes 2,018,749 sh (+5.05%)
Barrow, Hanley, Mewhinney & Strauss 316,036 sh (+3.50%)
Arnold Schneider 127,525 sh (unchged)
Mariko Gordon 2,922,828 sh (-1.69%)
HOTCHKIS & WILEY 1,338,095 sh (-3.42%)
» More
Q2 2017

IVC Guru Trades in Q2 2017

Leucadia National 12,204 sh (New)
Jim Simons 130,600 sh (New)
Arnold Schneider 288,770 sh (+126.44%)
Chuck Royce 1,354,739 sh (+11.80%)
Barrow, Hanley, Mewhinney & Strauss 316,036 sh (unchged)
HOTCHKIS & WILEY 1,330,505 sh (-0.57%)
Mariko Gordon 2,828,630 sh (-3.22%)
Charles Brandes 1,532,394 sh (-24.09%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2017-06-30 Reduce -3.22%0.07%$10.4 - $15.25 $ 15.7420%2,828,630
Charles Brandes 2017-06-30 Reduce -24.09%0.09%$10.4 - $15.25 $ 15.7420%1,532,394
HOTCHKIS & WILEY 2017-06-30 Reduce -0.57%$10.4 - $15.25 $ 15.7420%1,330,505
Arnold Schneider 2017-06-30 Add 126.44%0.4%$10.4 - $15.25 $ 15.7420%288,770
Leucadia National 2017-06-30 New Buy0.01%$10.4 - $15.25 $ 15.7420%12,204
Mariko Gordon 2017-03-31 Reduce -1.69%0.04%$11.15 - $13.7 $ 15.7431%2,922,828
Charles Brandes 2017-03-31 Add 5.05%0.02%$11.15 - $13.7 $ 15.7431%2,018,749
HOTCHKIS & WILEY 2017-03-31 Reduce -3.42%$11.15 - $13.7 $ 15.7431%1,338,095
Barrow, Hanley, Mewhinney & Strauss 2017-03-31 Add 3.50%$11.15 - $13.7 $ 15.7431%316,036
Mariko Gordon 2016-12-31 Reduce -0.37%0.01%$9.05 - $13.25 $ 15.7437%2,972,948
Mariko Gordon 2016-12-31 Reduce -0.37%0.01%Premium Member Access $13.05 $ 15.7421%2,972,948
Charles Brandes 2016-12-31 Add 33.78%0.1%$9.05 - $13.25 $ 15.7437%1,921,649
Charles Brandes 2016-12-31 Add 33.78%0.09%Premium Member Access $13.05 $ 15.7421%1,921,649
HOTCHKIS & WILEY 2016-12-31 Reduce -0.44%$9.05 - $13.25 $ 15.7437%1,385,495
Barrow, Hanley, Mewhinney & Strauss 2016-12-31 Add 13.48%$9.05 - $13.25 $ 15.7437%305,349
Arnold Schneider 2016-12-31 Reduce -6.58%0.02%$9.05 - $13.25 $ 15.7437%127,525
Mariko Gordon 2016-09-30 Add 131.94%1.16%$10.95 - $13.48 $ 15.7431%2,983,947
Charles Brandes 2016-09-30 Add 51.04%0.08%$10.95 - $13.48 $ 15.7431%1,436,472
HOTCHKIS & WILEY 2016-09-30 Reduce -0.39%$10.95 - $13.48 $ 15.7431%1,391,665
Barrow, Hanley, Mewhinney & Strauss 2016-09-30 Add 5.88%$10.95 - $13.48 $ 15.7431%269,082
Arnold Schneider 2016-09-30 Reduce -6.83%0.02%$10.95 - $13.48 $ 15.7431%136,505
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NAS:GNMK, NAS:CUTR, NAS:EXAC, NAS:AXGN, NAS:TCMD, NAS:ARAY, NAS:VRAY, AMEX:CVRS, NAS:RTIX, NYSE:CRY, ASX:RVA, OTCPK:BBLG, NAS:FONR, ASX:OSP, NAS:OBLN, NAS:CGNT, NAS:XENT, NAS:ACRX, NAS:KTWO, NAS:SPNE » details
Traded in other countries:IV3.Germany,
Headquarter Location:USA
Invacare Corp is a manufacturer and distributor of medical equipment used in non-acute care settings. The company sells its products to home medical equipment providers with retail and e-commerce channels, residential care operators, and distributors.

Invacare makes and distributes medical equipment used in non-acute care settings. Its products are primarily sold to home medical equipment providers, residential living operators, distributors, and government health services. The firm sells products in three categories: mobility and seating, lifestyle, and respiratory therapy. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, and positioning cushions. Its lifestyle products include manual wheelchairs, crutches, walkers, and homecare beds. Its respiratory products include stationary and portable oxygen concentrators and nondelivery oxygen technology. Invacare receives the largest proportion of revenue from sales in Europe.

Top Ranked Articles about Invacare Corp

Holdings Charles Brandes Continues to Increase Stocks he bought during the last 2 quarters
Charles Brandes (Trades, Portfolio) is the chairman of Brandes Investment Partners, the firm he started in 1974. In both the second and third quarters the guru bought shares in the following stocks: Read more...

Ratios

vs
industry
vs
history
PB Ratio 1.21
IVC's PB Ratio is ranked higher than
89% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. IVC: 1.21 )
Ranked among companies with meaningful PB Ratio only.
IVC' s PB Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.04 Max: 1.72
Current: 1.21
0.55
1.72
PS Ratio 0.51
IVC's PS Ratio is ranked higher than
93% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.32 vs. IVC: 0.51 )
Ranked among companies with meaningful PS Ratio only.
IVC' s PS Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.75
Current: 0.51
0.26
0.75
EV-to-EBIT -19.60
IVC's EV-to-EBIT is ranked lower than
99.99% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 24.67 vs. IVC: -19.60 )
Ranked among companies with meaningful EV-to-EBIT only.
IVC' s EV-to-EBIT Range Over the Past 10 Years
Min: -368.8  Med: -6.9 Max: 64.2
Current: -19.6
-368.8
64.2
EV-to-EBITDA -37.96
IVC's EV-to-EBITDA is ranked lower than
99.99% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 17.99 vs. IVC: -37.96 )
Ranked among companies with meaningful EV-to-EBITDA only.
IVC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1495  Med: 9.4 Max: 487
Current: -37.96
-1495
487
EV-to-Revenue 0.59
IVC's EV-to-Revenue is ranked higher than
95% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. IVC: 0.59 )
Ranked among companies with meaningful EV-to-Revenue only.
IVC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.5 Max: 1
Current: 0.59
0.3
1
Current Ratio 2.27
IVC's Current Ratio is ranked lower than
68% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.64 vs. IVC: 2.27 )
Ranked among companies with meaningful Current Ratio only.
IVC' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 2.21 Max: 3.34
Current: 2.27
1.38
3.34
Quick Ratio 1.53
IVC's Quick Ratio is ranked lower than
74% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. IVC: 1.53 )
Ranked among companies with meaningful Quick Ratio only.
IVC' s Quick Ratio Range Over the Past 10 Years
Min: 0.83  Med: 1.52 Max: 2.03
Current: 1.53
0.83
2.03
Days Inventory 75.09
IVC's Days Inventory is ranked higher than
81% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 128.08 vs. IVC: 75.09 )
Ranked among companies with meaningful Days Inventory only.
IVC' s Days Inventory Range Over the Past 10 Years
Min: 53.38  Med: 62.35 Max: 75.09
Current: 75.09
53.38
75.09
Days Sales Outstanding 46.41
IVC's Days Sales Outstanding is ranked higher than
83% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.17 vs. IVC: 46.41 )
Ranked among companies with meaningful Days Sales Outstanding only.
IVC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.53  Med: 51.7 Max: 64.57
Current: 46.41
40.53
64.57
Days Payable 45.50
IVC's Days Payable is ranked lower than
61% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 54.45 vs. IVC: 45.50 )
Ranked among companies with meaningful Days Payable only.
IVC' s Days Payable Range Over the Past 10 Years
Min: 34.47  Med: 46.5 Max: 55.1
Current: 45.5
34.47
55.1

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.32
IVC's Dividend Yield % is ranked lower than
84% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 1.14 vs. IVC: 0.32 )
Ranked among companies with meaningful Dividend Yield % only.
IVC' s Dividend Yield % Range Over the Past 10 Years
Min: 0.15  Med: 0.29 Max: 0.55
Current: 0.32
0.15
0.55
Forward Dividend Yield % 0.32
IVC's Forward Dividend Yield % is ranked lower than
85% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 1.51 vs. IVC: 0.32 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.33
IVC's 5-Year Yield-on-Cost % is ranked lower than
85% of the 235 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. IVC: 0.33 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IVC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.15  Med: 0.29 Max: 0.55
Current: 0.33
0.15
0.55
3-Year Average Share Buyback Ratio -0.40
IVC's 3-Year Average Share Buyback Ratio is ranked higher than
75% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. IVC: -0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
IVC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.4  Med: -0.7 Max: 0.4
Current: -0.4
-8.4
0.4

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 33.49
IVC's Price-to-Tangible-Book is ranked lower than
93% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 3.98 vs. IVC: 33.49 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
IVC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.51  Med: 6.92 Max: 94.62
Current: 33.49
1.51
94.62
Price-to-Intrinsic-Value-Projected-FCF 2.01
IVC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
79% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.41 vs. IVC: 2.01 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
IVC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.33  Med: 1.13 Max: 7.51
Current: 2.01
0.33
7.51
Price-to-Median-PS-Value 1.25
IVC's Price-to-Median-PS-Value is ranked lower than
52% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. IVC: 1.25 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
IVC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.62  Med: 1.67 Max: 3.83
Current: 1.25
0.62
3.83
Earnings Yield (Greenblatt) % -5.09
IVC's Earnings Yield (Greenblatt) % is ranked lower than
63% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. IVC: -5.09 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
IVC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -25.6  Med: -1.5 Max: 11
Current: -5.09
-25.6
11
Forward Rate of Return (Yacktman) % -21.36
IVC's Forward Rate of Return (Yacktman) % is ranked lower than
92% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.78 vs. IVC: -21.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
IVC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -21.9  Med: 8.6 Max: 20.4
Current: -21.36
-21.9
20.4

More Statistics

Revenue (TTM) (Mil) $980.13
EPS (TTM) $ -1.93
Beta2.53
Short Percentage of Float31.66%
52-Week Range $8.00 - 16.65
Shares Outstanding (Mil)32.87
» More Articles for IVC

Headlines

Articles On GuruFocus.com
Stakes Charles Brandes Continues to Increase Nov 14 2016 
Mariko Gordon Invested in 5 Companies in 2nd Quarter Aug 21 2016 
Royce Micro-Cap Discovery Fund Shareholder Letter Sep 20 2015 
Invacare Corporation: Sell First, Ask Questions Later? Feb 15 2012 
Invacare Corp. Reports Operating Results (10-K) Feb 25 2011 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2010 
Invacare Corp. Reports Operating Results (10-Q) Aug 06 2010 
Invacare Corp. Reports Operating Results (10-Q) May 06 2010 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2009 
Invacare Corp. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
5 Medtech Stocks to Steer Clear of Amid Political Chaos Sep 19 2017
Invacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : September 5, 2017 Sep 05 2017
See what the IHS Markit Score report has to say about Invacare Corp. Sep 02 2017
Invacare Corporation to Present at September 2017 Conferences Aug 31 2017
ETFs with exposure to Invacare Corp. : August 25, 2017 Aug 25 2017
Invacare Corporation Appoints Barbara Bodem to Board of Directors Aug 21 2017
Invacare Corp. breached its 50 day moving average in a Bearish Manner : IVC-US : August 18, 2017 Aug 18 2017
Invacare Declares Quarterly Dividend Aug 18 2017
Invacare Corp. :IVC-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Aug 16 2017
Invacare (IVC) Introduces TDX SP2 Power Wheelchair Globally Aug 16 2017
Invacare Launches Highly Anticipated TDX SP2 Power Wheelchair with LiNX Technology and Advanced... Aug 15 2017
Edited Transcript of IVC earnings conference call or presentation 8-Aug-17 12:30pm GMT Aug 13 2017
Investor Network: Invacare Corporation to Host Earnings Call Aug 08 2017
Invacare reports 2Q loss Aug 07 2017
Invacare Corp. – Value Analysis (NYSE:IVC) : August 7, 2017 Aug 07 2017
Invacare Reports Results for Second Quarter 2017 Aug 07 2017
Invacare Corporation Announces Transfer of Wheelchair Production from Sweden to France Jul 28 2017
Invacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : July 26, 2017 Jul 26 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}